Display options
Cite
Butelman ER, Kreek MJ. Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Front Pharmacol. 2015;6:285doi: 10.3389/fphar.2015.00285.
Butelman, E. R., & Kreek, M. J. (2015). Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Frontiers in pharmacology, 6285. https://doi.org/10.3389/fphar.2015.00285
Butelman, Eduardo R, and Kreek, Mary Jeanne. "Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders." Frontiers in pharmacology vol. 6 (2015): 285. doi: https://doi.org/10.3389/fphar.2015.00285
Butelman ER, Kreek MJ. Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Front Pharmacol. 2015 Nov 30;6:285. doi: 10.3389/fphar.2015.00285. eCollection 2015. PMID: 26648869; PMCID: PMC4663718.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2015 Nov 30;6:285. doi: 10.3389/fphar.2015.00285. eCollection 2015.

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.

Frontiers in pharmacology

Eduardo R Butelman, Mary Jeanne Kreek

Affiliations

  1. Laboratory on the Biology of Addictive Diseases, The Rockefeller University New York, NY, USA.

PMID: 26648869 PMCID: PMC4663718 DOI: 10.3389/fphar.2015.00285

Abstract

[This corrects the article on p. 190 in vol. 6, PMID: 26441647.].

Keywords: Salvia divinorum; addiction; depression; dynorphins; kappa-opioid receptor; salvinorin A

References

  1. Psychopharmacology (Berl). 2014 Jul;231(14 ):2751-8 - PubMed

Publication Types